Usual risk factors do not predict venous thromboembolism in newly diagnosed myeloma treated with immunomodulatory drugs

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|91|10|E455-E456

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.91, Iss.10, 2016-10, pp. : E455-E456

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Acquired Risk Factors of Venous Thromboembolism in Medical Patients

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 35, Iss. 1-2, 2006-06 ,pp. : 128-132

Karger

Access to resources Recommend Favorite

Principle Mechanisms Underlying Venous Thromboembolism: Epidemiology, Risk Factors, Pathophysiology and Pathogenesis

By  

Respiration, Vol. 70, Iss. 1, 2003-02 ,pp. : 7-30

Karger

Access to resources Recommend Favorite

Risk Factors of Recurrent Venous Thromboembolism: The Role of Residual Vein Thrombosis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 5-6, 2005-01 ,pp. : 351-353

Karger

Access to resources Recommend Favorite

New epidemiological risk factors for venous thromboembolism (VTE) after menopause

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 70-70

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard‐risk cytogenetics

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 4, 2015-08 ,pp. : 523-531

John Wiley & Sons Inc

Access to resources Recommend Favorite